Ophthalmic Business Council
For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.
OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.
To join or learn more, contact Todd Lyckberg at 415.447.0361 or email@example.com.
Download brochures: AAO 2023-24 exhibitors and non-exhibitors
Save the Date
2023-24 OBC Membership Brochure Non-Exhibitor.pdf
Fall 2023 Symposium
Sept. 21-22, 2023
San Francisco, Calif.
Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.
Spring 2025 Symposium
The Spring Symposium is held every other year in Washington, D.C. It features experts from government agencies presenting updates on FDA, Medicare and reimbursement issues. As the speed of innovation and new knowledge in ophthalmology grows, this event has become increasingly valuable in providing helpful insights for bringing new technologies and procedures to patients.
2023 - 2024 Ophthalmic Business Council
Crown Benefactors ($35,000)
Allergan, an AbbVie Company
Regeneron Pharmaceuticals Inc.
The Janssen Pharmaceutical Companies of Johnson & Johnson
Sight Sciences Inc.
Bausch + Lomb
Carl Zeiss Meditec Inc.
Johnson & Johnson Vision
Coherus BioSciences Inc.
Leadiant Biosciences Inc.
Tarsus Pharmaceuticals Inc.
Associate Members ($2,500)
W. L. Gore & Associates